July/August 2016
Potentially Inappropriate Prescribing of Direct-acting Oral Anticoagulants in the Veterans Health Administration
August 19, 2016
Article
Original Research
This study examines variations in overall use, and potentially inappropriate use, of non-warfarin direct-acting oral anticoagulants across sites within the Veterans Health Administration.
E-Prescribing With Decision Support Is Associated With Improvements in Medication Adherence
August 18, 2016
Article
Original Research
This study evaluates whether provider adoption and use of formulary decision support for e-prescribing are directly associated with significant prescriber and patient behavior change.
The Impact of Rare Diseases and Drug Therapy
August 18, 2016
Article
Specialty Healthcare Benefits Council
The development and implementation of a rare disease management program by healthcare providers and payors could greatly assist in improving the clinical, psycho-social and economic impacts for this patient population.
Private-payer Costs for Employees with Treatment-resistant Depression
August 18, 2016
Article
Original Research
Individuals with treatment-resistant depression do not achieve and sustain remission after multiple pharmacotherapies, with an unknown impact on employment. This study investigates the expenditures of TRD from a private-payer perspective in Canada.
Factors Associated with Zostavax Abandonment
August 18, 2016
Article
Original Research
This study highlights the implications of noncompliance with the use of in-network providers for immunization services, shedding light on value-based benefits design to promote access to recommended vaccinations.
Partial-Fill Programs: Good Practice or Barrier to Care
August 18, 2016
Article
From the Editor
Specialty-focused partial-fill plan designs are gaining traction, with conflicting opinions on whether they reduce waste or impact the quality of care.
Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial Fibrillation
August 18, 2016
Article
Original Research
This study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.
Pharmacoeconomics of ColciGel for the Treatment of Acute Gout Flares
August 17, 2016
Article
Original Research
The pharmacoeconomic impact of treating acute gout flares with ColciGel or with oralcolchicine.